Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression

被引:282
作者
Ariel, Amiram
Fredman, Gabrielle
Sun, Yee-Ping
Kantarci, Alpdogan
Van Dyke, Thomas E.
D Luster, Andrew
Serhan, Charles N.
机构
[1] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Boston Univ, Dept Periodontol & Oral Biol, Goldman Sch Grad Dent, Boston, MA 02118 USA
[4] Harvard Univ, Sch Med, Ctr Immunol & Inflammatory Dis, Massachusetts Gen Hosp,Div Rheumatol Allergy & Im, Charlestown, MA 02129 USA
关键词
D O I
10.1038/ni1392
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During the resolution phase of inflammation, the 'corpses' of apoptotic leukocytes are gradually cleared by macrophages. Here we report that during the resolution of peritonitis, the CCR5 chemokine receptor ligands CCL3 and CCL5 persisted in CCR5-deficient mice. CCR5 expression on apoptotic neutrophils and activated apoptotic T cells sequestered and effectively cleared CCL3 and CCL5 from sites of inflammation. CCR5 expression on late apoptotic human polymorphonuclear cells was downregulated by proinflammatory stimuli, including tumor necrosis factor, and was upregulated by 'proresolution' lipid mediators, including lipoxin A(4), resolvin E1 and protectin D1. Our results suggest that CCR5(+) apoptotic leukocytes act as 'terminators' of chemokine signaling during the resolution of inflammation.
引用
收藏
页码:1209 / 1216
页数:8
相关论文
共 51 条
  • [21] Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice
    Hanayama, R
    Tanaka, M
    Miyasaka, K
    Aozasa, K
    Koike, M
    Uchiyama, Y
    Nagata, S
    [J]. SCIENCE, 2004, 304 (5674) : 1147 - 1150
  • [22] Hebert MJ, 1996, J IMMUNOL, V157, P3105
  • [23] Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV β-chemokines:: An approach to suppress R5 strains of HIV-1
    Heredia, A
    Amoroso, A
    Davis, C
    Le, N
    Reardon, E
    Dominique, JK
    Klingebiel, E
    Gallo, RC
    Redfield, RR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) : 10411 - 10416
  • [24] Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638
  • [25] The chemokine receptor D6 limits the inflammatory response in vivo
    Jamieson, T
    Cook, DN
    Nibbs, RJB
    Rot, A
    Nixon, C
    Mclean, P
    Alcami, A
    Lira, SA
    Wiekowski, M
    Graham, GJ
    [J]. NATURE IMMUNOLOGY, 2005, 6 (04) : 403 - 411
  • [26] Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells
    Kim, SJ
    Elkon, KB
    Ma, XJ
    [J]. IMMUNITY, 2004, 21 (05) : 643 - 653
  • [27] SMM-chemokines: A class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development
    Kumar, S
    Choi, WT
    Dong, CZ
    Madan, N
    Tian, SM
    Liu, SX
    Wang, YL
    Pesavento, J
    Wang, J
    Fan, XJ
    Yuan, J
    Fritzsche, WR
    An, J
    Sodroski, JG
    Richman, DD
    Huang, ZW
    [J]. CHEMISTRY & BIOLOGY, 2006, 13 (01): : 69 - 79
  • [28] CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice
    Kuziel, WA
    Dawson, TC
    Quinones, M
    Garavito, E
    Chenaux, G
    Ahuja, SS
    Reddick, RL
    Maeda, N
    [J]. ATHEROSCLEROSIS, 2003, 167 (01) : 25 - 32
  • [29] Lipid mediator class switching during acute inflammation: signals in resolution
    Levy, BD
    Clish, CB
    Schmidt, B
    Gronert, K
    Serhan, CN
    [J]. NATURE IMMUNOLOGY, 2001, 2 (07) : 612 - 619
  • [30] Immune cell migration in inflammation: present and future therapeutic targets
    Luster, AD
    Alon, R
    von Andrian, UH
    [J]. NATURE IMMUNOLOGY, 2005, 6 (12) : 1182 - 1190